Adverse Events with Amiodarone-Will the List Ever End?
作者信息
Reiffel James A
机构信息
Department of Medicine, Division of Cardiology, Electrophysiology Section, Columbia University, New York, NY, USA.
出版信息
J Innov Card Rhythm Manag. 2018 Mar 15;9(3):3077-3078. doi: 10.19102/icrm.2018.090307. eCollection 2018 Mar.
Abstract
摘要
相似文献
1
Adverse Events with Amiodarone-Will the List Ever End?胺碘酮的不良事件——这份清单会有尽头吗？
J Innov Card Rhythm Manag. 2018 Mar 15;9(3):3077-3078. doi: 10.19102/icrm.2018.090307. eCollection 2018 Mar.
2
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by amiodarone: a report on two cases.胺碘酮诱发的抗利尿激素分泌不当综合征（SIADH）：两例报告
J Cardiovasc Pharmacol Ther. 2002 Jan;7(1):25-8. doi: 10.1177/107424840200700i104.
3
Syndrome of inappropriate antidiuretic hormone-induced hyponatremia associated with amiodarone.与胺碘酮相关的抗利尿激素分泌不当综合征所致低钠血症
Pharmacotherapy. 2002 May;22(5):649-51. doi: 10.1592/phco.22.8.649.33206.
4
5
Hyponatremia - a rare but serious complication of amiodarone: a case report and review of the literature.低钠血症——胺碘酮一种罕见但严重的并发症：一例病例报告及文献综述
Case Rep Nephrol Urol. 2013 Apr 19;3(1):46-50. doi: 10.1159/000350910. Print 2013 Jan.
6
Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials.使用随机对照试验数据对比胺碘酮不良事件与安慰剂的数据集。
Data Brief. 2019 Nov 18;28:104835. doi: 10.1016/j.dib.2019.104835. eCollection 2020 Feb.
7
Syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy.胺碘酮治疗引起的抗利尿激素分泌不当综合征。
Pacing Clin Electrophysiol. 2004 Jun;27(6 Pt 1):831-2. doi: 10.1111/j.1540-8159.2004.00541.x.
8
Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo.胺碘酮与安慰剂不良事件相对风险的荟萃分析比较。
Am J Cardiol. 2019 Dec 15;124(12):1889-1893. doi: 10.1016/j.amjcard.2019.09.008. Epub 2019 Sep 26.
9
Amiodarone-induced SIADH: two cases report.胺碘酮诱发的抗利尿激素分泌异常综合征：两例报告
Endocr Metab Immune Disord Drug Targets. 2014;14(2):123-5. doi: 10.2174/1871530314666140407111410.
10
Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice.监测胺碘酮的毒性：建议、证据与临床实践
Clin Pharmacol Ther. 2004 Jan;75(1):110-22. doi: 10.1016/j.clpt.2003.09.010.
引用本文的文献
1
Pulmonary Fibrosis Related to Amiodarone-Is It a Standard Pathophysiological Pattern? A Case-Based Literature Review.胺碘酮相关的肺纤维化——它是一种标准的病理生理模式吗？基于病例的文献综述。
Diagnostics (Basel). 2022 Dec 19;12(12):3217. doi: 10.3390/diagnostics12123217.
本文引用的文献
1
Amiodarone-induced Hyponatremia: A Case Report and a Review of the Literature.胺碘酮所致低钠血症：一例病例报告及文献综述
J Innov Card Rhythm Manag. 2018 Mar 15;9(3):3071-3076. doi: 10.19102/icrm.2018.090303. eCollection 2018 Mar.
2
Patient and medication-related factors associated with hospital-acquired hyponatremia in patients hospitalized from heart failure.心力衰竭住院患者中与医院获得性低钠血症相关的患者及药物相关因素。
Int J Clin Pharm. 2016 Aug;38(4):848-54. doi: 10.1007/s11096-016-0296-3. Epub 2016 Apr 4.
3
4
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.胺碘酮：电生理作用、药代动力学及临床效应
J Am Coll Cardiol. 1984 Apr;3(4):1059-71. doi: 10.1016/s0735-1097(84)80367-8.
5
A general overview of amiodarone toxicity: its prevention, detection, and management.胺碘酮毒性概述：预防、检测与处理
Prog Cardiovasc Dis. 1989 May-Jun;31(6):393-426. doi: 10.1016/0033-0620(89)90016-9.
6
Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.胺碘酮。其药理特性概述及其在心律失常治疗中的应用综述。
Drugs. 1992 Jan;43(1):69-110. doi: 10.2165/00003495-199243010-00007.
Zotero 插件